Sorafenib-Associated Facial Acneiform Eruption

    December 2014 in “ Dermatology and therapy ”
    Philip R. Cohen
    Studysummary This study reports that sorafenib-associated facial acneiform eruption, mimicking chloracne, is a rare cutaneous adverse event which improved upon reducing or discontinuing the drug.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. Acne Inversa-Like Lesions Associated With The Multi-Kinase Inhibitor Sorafenib Clinical and Experimental Dermatology · 2013
    2. A Distinct Cutaneous Reaction to Sorafenib and a Multikinase Inhibitor International Journal of Dermatology · 2008